Our Drug Discovery Story

Expert Consulting Solutions for Drug Discovery Problems

Medicinal chemist and drug discovery leader with 20+ years of experience and a successful track record, including seven IND filings and one FDA-approved drug (Revumenib).
Proficient in SBDD, FBDD, HTS, DEL, and non-classical modalities such as PROTACs, molecular glues, cyclic peptides, covalent, and allosteric modulators.
Broad therapeutic expertise in oncology, neurology, immunology, virology, and metabolic diseases.
Strong knowledge in SAR, ADME, biophysics, and API synthesis. Inventor of 30+ granted US patents. Experienced in managing teams, cross-functional collaborations, and large external partnerships.

10+ years of leadership experience managing multidisciplinary teams (chemistry, DMPK, pharmacology) in matrix environments.

Directed programs resulting in $500M in upfront deal value and over $2B in potential milestones.

Extensive experience managing strategic collaborations (e.g., Boehringer Ingelheim, Merck) and external CRO networks (chemistry, DMPK, HTS).

Skilled in setting R&D strategy, budget, and timelines, ensuring on-time delivery of milestones.

Certified in Project Management and QA/RA for drug development, bridging science with regulatory and business objectives.